XENE - Xenon Pharmaceuticals Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$85.00
DETAILS
HIGH:
$100.00
LOW:
$60.00
MEDIAN:
$89.50
CONSENSUS:
$85.00
UPSIDE:
56.91%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Druckenmiller | 238,600 | $13.9M | 0.4% | +238,600 | NEW |
| Cooperman | 18,940 | $1.1M | 0.0% | -11,911 | DECREASED |
| Wood | 9,300 | $540,795 | 0.0% | -- | UNCHANGED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-05-12 | GANNON STEVEN | director | M-Exempt | 3,500 | $7.38 | $26K |
| 2026-03-13 | KENNEY CHRISTOPHER JOHN | officer: Chief Medical Officer | SELL | 1,410 | $55.23 | $78K |
| 2026-03-12 | MORTIMER IAN | director, officer: PRESIDENT & CEO | M-Exempt | 12,500 | -- | -- |
| 2026-03-13 | MORTIMER IAN | director, officer: PRESIDENT & CEO | SELL | 7,308 | $55.23 | $404K |
| 2026-03-13 | DiFabio Andrea | officer: Chief Legal Officer | SELL | 1,342 | $55.23 | $74K |
| 2026-03-12 | KENNEY CHRISTOPHER JOHN | officer: Chief Medical Officer | M-Exempt | 3,750 | -- | -- |
| 2026-03-12 | DiFabio Andrea | officer: Chief Legal Officer | M-Exempt | 3,750 | -- | -- |
| 2026-03-09 | MORTIMER IAN | director, officer: PRESIDENT & CEO | SELL | 12,479 | $59.50 | $742K |
| 2026-03-10 | MORTIMER IAN | director, officer: PRESIDENT & CEO | SELL | 11,269 | $60.11 | $677K |
| 2026-03-09 | MORTIMER IAN | director, officer: PRESIDENT & CEO | M-Exempt | 25,000 | $3.10 | $78K |
| 2026-03-09 | KENNEY CHRISTOPHER JOHN | officer: Chief Medical Officer | A-Award | 7,500 | -- | -- |
| 2026-03-09 | DiFabio Andrea | officer: Chief Legal Officer | A-Award | 7,500 | -- | -- |
| 2026-03-09 | MORTIMER IAN | director, officer: PRESIDENT & CEO | SELL | 21,791 | $58.81 | $1.3M |
| 2026-03-09 | MORTIMER IAN | director, officer: PRESIDENT & CEO | SELL | 2,449 | $61.26 | $150K |
| 2026-03-09 | MORTIMER IAN | director, officer: PRESIDENT & CEO | SELL | 10,072 | $60.47 | $609K |
| 2026-03-09 | MORTIMER IAN | director, officer: PRESIDENT & CEO | SELL | 65,000 | $62.06 | $4.0M |
| 2026-03-09 | MORTIMER IAN | director, officer: PRESIDENT & CEO | M-Exempt | 105,000 | $4.75 | $499K |
| 2026-03-09 | MORTIMER IAN | director, officer: PRESIDENT & CEO | SELL | 21,515 | $60.49 | $1.3M |
| 2026-03-09 | MORTIMER IAN | director, officer: PRESIDENT & CEO | M-Exempt | 20,000 | -- | -- |
| 2026-03-10 | DiFabio Andrea | officer: Chief Legal Officer | SELL | 2,607 | $60.11 | $157K |
| 2026-03-09 | DiFabio Andrea | officer: Chief Legal Officer | M-Exempt | 7,500 | -- | -- |
| 2026-03-09 | MORTIMER IAN | director, officer: PRESIDENT & CEO | SELL | 43,348 | $59.26 | $2.6M |
| 2026-03-09 | MORTIMER IAN | director, officer: PRESIDENT & CEO | SELL | 61,652 | $60.08 | $3.7M |
| 2026-03-09 | MORTIMER IAN | director, officer: PRESIDENT & CEO | SELL | 31,694 | $59.88 | $1.9M |
| 2026-03-09 | MORTIMER IAN | director, officer: PRESIDENT & CEO | A-Award | 20,000 | -- | -- |